Items where authors include "Harnan, S."
Up a levelArticle
Cooper, K. orcid.org/0000-0002-7702-8103, Campbell, F., Harnan, S. et al. (1 more author) (2023) Association between stress, depression or anxiety and cancer: Rapid review of reviews. Comprehensive Psychoneuroendocrinology. 100215. ISSN 2666-4976
Poku, E. orcid.org/0000-0001-6549-5081, Cooper, K., Cantrell, A. et al. (4 more authors) (2023) Systematic review of time lag between antibiotic use and rise of resistant pathogens among hospitalized adults in Europe. JAC-Antimicrobial Resistance, 5 (1). dlad001. ISSN 2632-1823
Rafia, R., Martyn-St James, M., Harnan, S. et al. (3 more authors) (2022) A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales. Value in Health, 25 (5). pp. 761-769. ISSN 1098-3015
Poku, E. orcid.org/0000-0001-6549-5081, Harnan, S., Rooney, G. orcid.org/0000-0002-8388-9444 et al. (5 more authors) (2022) The relationship between chronic kidney disease–associated pruritus and health-related quality of life: a systematic review. Clinical Kidney Journal, 15 (3). pp. 484-499. ISSN 2048-8505
Phang Romero Casas, C., Martyn-St James, M. orcid.org/0000-0002-4679-7831, Hamilton, J. et al. (3 more authors) (2022) Rapid diagnostic test for antenatal syphilis screening in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Open, 8 (2). e018132. ISSN 2044-6055
Vilaca, T., Salam, S. orcid.org/0000-0001-9236-3906, Schini, M. orcid.org/0000-0003-2204-2095 et al. (6 more authors) (2020) Risks of hip and nonvertebral fractures in patients with CKD G3a-G5D: a systematic review and meta-analysis. American Journal of Kidney Diseases, 76 (4). pp. 521-532. ISSN 0272-6386
Vilaca, T., Schini, M. orcid.org/0000-0003-2204-2095, Harnan, S. orcid.org/0000-0002-9318-9206 et al. (5 more authors) (2020) The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update. Bone, 137. 115457. ISSN 8756-3282
Schini, M. orcid.org/0000-0003-2204-2095, Vilaca, T., Poku, E. orcid.org/0000-0001-6549-5081 et al. (5 more authors) (2020) The risk of hip and non-vertebral fractures in patients with Parkinson's disease and parkinsonism : a systematic review and meta-analysis. Bone, 132. ISSN 8756-3282
Harnan, S. orcid.org/0000-0002-9318-9206, Tappenden, P. orcid.org/0000-0001-6612-2332, Cooper, K. orcid.org/0000-0002-7702-8103 et al. (7 more authors) (2019) Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis. Health Technology Assessment, 23 (30). ISSN 1366-5278
Mukuria, C., Rowen, D. orcid.org/0000-0003-3018-5109, Harnan, S. et al. (4 more authors) (2019) An updated systematic review of studies mapping (or cross walking) measures of health related-quality of life to generic preference-based measures to generate utility values. Applied Health Economics and Health Policy, 17 (3). pp. 295-313. ISSN 1175-5652
Rafia, R. orcid.org/0000-0002-6914-1990, Pandor, A. orcid.org/0000-0003-2552-5260, Davis, S. orcid.org/0000-0002-6609-4287 et al. (5 more authors) (2018) Obinutuzumab with Bendamustine for Treating Follicular Lymphoma Refractory to Rituximab: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 36 (10). pp. 1143-1151. ISSN 1170-7690
Bermejo, I. orcid.org/0000-0001-9105-8088, Stevenson, M. orcid.org/0000-0002-3099-9877, Cooper, K. orcid.org/0000-0002-7702-8103 et al. (6 more authors) (2018) Mepolizumab for treating severe eosinophilic asthma: an evidence review group perspective of a NICE single technology appraisal. Pharmacoeconomics, 36. pp. 131-144. ISSN 1170-7690
Cree, I., Uttley, L., Woods, H.B. et al. (11 more authors) (2017) The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review. BMC Cancer, 17. 697.
Tappenden, P. orcid.org/0000-0001-6612-2332, Harnan, S. orcid.org/0000-0002-9318-9206, Ren, S. et al. (6 more authors) (2016) Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. ISSN 1170-7690
Rafia, R. orcid.org/0000-0002-6914-1990, Scope, A. orcid.org/0000-0003-1604-1758, Harnan, S. orcid.org/0000-0002-9318-9206 et al. (3 more authors) (2016) Vedolizumab for Treating Moderately to Severely Active Crohn’s Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. ISSN 1170-7690
Uttley, L., Whiteman, B.L., Woods, H.B. et al. (3 more authors) (2016) Building the Evidence Base of Blood-Based Biomarkers for Early Detection of Cancer: A Rapid Systematic Mapping Review. EBioMedicine. ISSN 2352-3964
Harnan, S. orcid.org/0000-0002-9318-9206, Ren, S., Gomersall, T. et al. (4 more authors) (2016) Association Between Transfusion Status and Overall Survival in Patients With Myelodysplastic Syndromes: A Systematic Literature Review and Meta-Analysis. Acta Haematologica, 136 (1). pp. 23-42. ISSN 0001-5792
Essat, M., Harnan, S., Gomersall, T. et al. (5 more authors) (2016) Fractional exhaled nitric oxide for the management of asthma in adults: Systematic review. European Respiratory Society. ISSN 0903-1936
Pickering, A., Cooper, K., Harnan, S. et al. (3 more authors) (2015) Impact of prehospital transfer strategies in major trauma and head injury: Systematic review, meta-analysis, and recommendations for study design. Journal of Trauma and Acute Care Surgery, 78 (1). pp. 164-177. ISSN 2163-0755
Whyte, S. orcid.org/0000-0002-7963-2523 and Harnan, S. orcid.org/0000-0002-9318-9206 (2014) Effectiveness and cost-effectiveness of an awareness campaign for colorectal cancer: a mathematical modeling study. Cancer Causes & Control, 25 (6). pp. 647-658. ISSN 0957-5243
Ward, S., Scope, A., Rafia, R. et al. (4 more authors) (2013) Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis. Health Technology Assessment, 17 (44). ISSN 1366-5278
Monograph
Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National Clinical Audit programme? APPENDIX C, INFLAMMATORY BOWEL DISEASE. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) . Policy Research Unit in Economic Evaluation of Health and Care Interventions
Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0031). Policy Research Unit in Economic Evaluation of Health and Care Interventions
Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix E - Diabetes. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0032). Policy Research Unit in Economic Evaluation of Health and Care Interventions
Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) . Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0032). Policy Research Unit in Economic Evaluation of Health and Care Interventions
Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix G - Head and Neck Cancer. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) . Policy Research Unit in Economic Evaluation of Health and Care Interventions
Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix H - Psychological Therapies. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0037). Policy Research Unit in Economic Evaluation of Health and Care Interventions
Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix I - Schizophrenia. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0035). Policy Research Unit in Economic Evaluation of Health and Care Interventions
Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix J - Dementia. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0037). Policy Research Unit in Economic Evaluation of Health and Care Interventions
Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix K - Cardiovascular. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0038). Policy Research Unit in Economic Evaluation of Health and Care Interventions
Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Project Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (29). Policy Research Unit in Economic Evaluation of Health and Care Interventions
Whyte, S., Harnan, S., Scope, A. et al. (8 more authors) (2012) Early awareness interventions for cancer: Colorectal cancer. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (EEPRU 004). Policy Research Unit in Economic Evaluation of Health and Care Interventions
Proceedings Paper
Vilaca, T., Schini, M. orcid.org/0000-0003-2204-2095, Harnan, S. orcid.org/0000-0002-9318-9206 et al. (3 more authors) (2020) SUN-622 The risk of hip and non-vertebral fractures in diabetes : a systematic review and meta-analysis update. In: Journal of the Endocrine Society. Annual Meeting of the Endocrine Society - ENDO 2020 (cancelled), 28-31 Mar 2020, San Francisco, CA, USA. The Endocrine Society .